Resultados de la búsqueda 391-400 of 14334 for Severe hyperkalaemia

  1. Centros vasculares - Ensayos clínicos

    The purpose of this study is to validate the use of a lymphatic imaging protocol to stage disease severity in patients with lymphedema and serve as a biomarker ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

  3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ... acute kidney injury provides strong predictive ability for AKI and potential therapeutic targets. ... acute kidney injury provides strong predictive ...

  4. Médicos y departamentos

    https://ginasthma.org/gina-reports/. Accessed March 27, 2020. Khurana S, et al. Systematic approach to asthma of varying severity. Clinics in Chest Medicine.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    This proposal will begin intense lymphedema screening and identify baseline characteristics potentially predisposing someone to lymphedema, and identify ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to validate the use of a lymphatic imaging protocol to stage disease severity in patients with lymphedema and serve as a biomarker ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...